A systematic comparison of hepatobiliary adverse drug reactions in FDA and EMA drug labeling reveals discrepancies

Drug Discovery Today - Tập 27 - Trang 337-346 - 2022
Yue Wu1, Wenzhong Xiao2,3, Weida Tong1, Jürgen Borlak4, Minjun Chen1
1Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA
2Harvard Medical School, Boston, MA, USA
3Massachusetts General Hospital, Boston, MA, USA
4Center of Pharmacology and Toxicology, Hannover Medical School, 30625 Hannover, Germany

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Drug Discovery Today

Tập 27

337-346

Thông tin tác giả